Summary of Product Characteristics
last updated on the eMC:
27/08/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27/08/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 2 - Qualitative and quantitative composition
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
-
Change to section 6. 6 - Instructions for use, handling and disposal
|
|
Updated on 12/07/2001 and displayed until 27/08/2009
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 22/06/2001 and displayed until 12/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 22/06/2001
|
Reasons for adding or updating:
|
|
|
|